Characterization of a Bioprinted Anticancer Cell Therapy System Generated with Continuous Liquid Interface Production
Open Access
- 2 October 2025
- journal article
- Published by Wiley in Advanced NanoBiomed Research
- Vol. 5 (10)
Abstract
Anticancer cell therapies have remarkable clinical potential yet fail to reach the clinic due to poor delivery. 3D bioprinting (3DBP) can be leveraged for generating cell therapy delivery devices, where the biomaterial system acts as a protective matrix to stabilize cells after implantation. Continuous liquid interface production (CLIP), an additive manufacturing technology, has several unique features that make it a suitable platform for 3DBP of cell‐laden scaffolds. However, the feasibility CLIP bioprinting and efficacy of CLIP‐bioprinted cell/matrix therapies have not yet been explored. In this work, we demonstrate the utility of CLIP for cell therapy 3DBP with a simple gelatin methacrylate‐based resin and anticancer drug‐secreting fibroblasts as a model therapy against recurrent glioblastoma. We demonstrate that CLIP enables rapid, consistent production of cell‐laden scaffolds, and cells maintain their viability and tumor‐killing efficacy in vitro post‐printing. Importantly, we proved that bioprinted cells survive longer in vivo than directly injected cells, and that this effect may correspond to better survival outcomes in a mouse model of glioblastoma resection. This study is the first to utilize CLIP for 3DBP of composite devices containing anticancer cell therapies, providing a crucial foundation for developing highly refined cell therapy delivery devices in the future.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (F31NS134198)
- National Institutes of Health (S10OD026951)
This publication has 41 references indexed in Scilit:
- Development of a biocompatible 3D hydrogel scaffold using continuous liquid interface production for the delivery of cell therapies to treat recurrent glioblastomaBioengineering & Translational Medicine, 2024
- Cell therapies in the clinicBioengineering & Translational Medicine, 2021
- Biomaterials for Personalized Cell TherapyAdvanced Materials, 2019
- Three-dimensional bioprinting of gelatin methacryloyl (GelMA)Bio-Design and Manufacturing, 2018
- Three‐dimensional extrusion bioprinting of single‐ and double‐network hydrogels containing dynamic covalent crosslinksJournal of Biomedical Materials Research Part A, 2018
- Controlling Shear Stress in 3D Bioprinting is a Key Factor to Balance Printing Resolution and Stem Cell IntegrityAdvanced Healthcare Materials, 2015
- TEGDMA‐induced toxicity in human fibroblasts is associated with early and drastic glutathione depletion with subsequent production of oxygen reactive speciesJournal of Biomedical Materials Research Part A, 2003
- Cellular response to oxidative stress: Signaling for suicide and survival*Journal of Cellular Physiology, 2002
- Free radicals and side products released during methylmethacrylate polymerization are cytotoxic for osteoblastic cellsJournal of Biomedical Materials Research, 1998
- Structure-toxicity relationship of acrylates and methacrylatesToxicology Letters, 1982